Bevacizumab in Combination With Radiotherapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme

Por van Linde, Myra E., Verhoeff, Joost J.C., Richel, Dirk J., van Furth, Wouter R., Reijneveld, Jaap C., Verheul, Henk M.W., Stalpers, Lukas J.A.
Publicado no Oncologist (2015)

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis

Por Lamba, Nayan, Muskens, Ivo S., DiRisio, Aislyn C., Meijer, Louise, Briceno, Vanessa, Edrees, Heba, Aslam, Bilal, Minhas, Sadia, Verhoeff, Joost J. C., Kleynen, Catharina E., Smith, Timothy R., Mekary, Rania A., Broekman, Marike L.
Publicado no Radiat Oncol (2017)

In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150(Glued)

Por van Lith, Sanne A.M., Roodink, Ilse, Verhoeff, Joost J.C., Mäkinen, Petri I., Lappalainen, Jari P., Ylä-Herttuala, Seppo, Raats, Jos, van Wijk, Erwin, Roepman, Ronald, Letteboer, Stef J., Verrijp, Kiek, Leenders, William P.J.
Publicado no Oncotarget (2016)

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma

Por Svendsen, Agnete, Verhoeff, Joost J. C., Immervoll, Heike, Brøgger, Jan C., Kmiecik, Justyna, Poli, Aurelie, Netland, Inger A., Prestegarden, Lars, Planagumà, Jesús, Torsvik, Anja, Kjersem, Anneli Bohne, Sakariassen, Per Ø., Heggdal, Jan I., Van Furth, Wouter R., Bjerkvig, Rolf, Lund-Johansen, Morten, Enger, Per Ø., Felsberg, Joerg, Brons, Nicolaas H. C., Tronstad, Karl J., Waha, Andreas, Chekenya, Martha
Publicado em 2011